A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Assessing new blood cells growth after transplant using cord blood units that do not meet FDA guidelines but meet NMDP guidelines
Summary
- Location
- at UCLA UCSD UCSF
- Dates
- study startedestimated completion
- Principal Investigator
- by Edward Ball, MD (ucsd)Gary Schiller, MD (ucla)Mark Walters, MD (ucsf)Thomas Martin, MD (ucsf)Sandhya Kharbanda, MD (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientists at University of California Health
- Edward Ball, MD (ucsd)
Dr. Ball’s research focuses on the development of monoclonal antibody (mAb)-targeted immunotherapy and its translation to the treatment of patients with malignancy. His lab produced mAbs to myeloid-associated antigens expressed on myeloid leukemia cells. - Gary Schiller, MD (ucla)
Professor-in-Residence, Medicine. Authored (or co-authored) 134 research publications - Mark Walters, MD (ucsf)
The over-arching goal of my research career has been to develop and expand curative therapies for hemoglobin disorders in particular and non-malignant hematopoietic disorders more broadly. I have focused on genome editing approaches most recently, which rely upon modification of autologous hematopoietic cells to elicit a curative effect. - Thomas Martin, MD (ucsf)
Professor, Medicine, School of Medicine. Authored (or co-authored) 72 research publications - Sandhya Kharbanda, MD (ucsf)
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 37 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Center for International Blood and Marrow Transplant Research
- ID
- NCT01351545
- Study Type
- Observational
- Participants
- Expecting 99999 study participants
- Last Updated